These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16260749)

  • 81. Human T-cell leukemia virus type 1 Tax shuttles between functionally discrete subcellular targets.
    Burton M; Upadhyaya CD; Maier B; Hope TJ; Semmes OJ
    J Virol; 2000 Mar; 74(5):2351-64. PubMed ID: 10666266
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
    Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
    AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
    [TBL] [Abstract][Full Text] [Related]  

  • 83. HIV-1 Tat directly binds to NFkappaB enhancer sequence: role in viral and cellular gene expression.
    Dandekar DH; Ganesh KN; Mitra D
    Nucleic Acids Res; 2004; 32(4):1270-8. PubMed ID: 14981150
    [TBL] [Abstract][Full Text] [Related]  

  • 84. On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation.
    Verhoef K; Bauer M; Meyerhans A; Berkhout B
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1553-9. PubMed ID: 9840288
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.
    Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W
    Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
    Verhoef K; Tijms M; Berkhout B
    Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.
    Zhu Y; Pe'ery T; Peng J; Ramanathan Y; Marshall N; Marshall T; Amendt B; Mathews MB; Price DH
    Genes Dev; 1997 Oct; 11(20):2622-32. PubMed ID: 9334325
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The HIV-1 Tat transactivator protein: a therapeutic target?
    Fulcher AJ; Jans DA
    IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
    Majello B; Napolitano G; Lania L
    AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inhibition of Tat transactivation by the RNA polymerase II CTD-phosphatase FCP1.
    Licciardo P; Napolitano G; Majello B; Lania L
    AIDS; 2001 Feb; 15(3):301-7. PubMed ID: 11273209
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription.
    Kusano S; Eizuru Y
    Biochem Biophys Res Commun; 2010 Jun; 396(3):608-13. PubMed ID: 20417616
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus.
    Li CJ; Wang C; Pardee AB
    J Biol Chem; 1994 Mar; 269(10):7051-4. PubMed ID: 8125909
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 95. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
    Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
    Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
    Jeang KT; Berkhout B
    J Biol Chem; 1992 Sep; 267(25):17891-9. PubMed ID: 1517225
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
    Elangovan B; Subramanian T; Chinnadurai G
    J Virol; 1992 Apr; 66(4):2031-6. PubMed ID: 1548750
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
    Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
    Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
    J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.